Could Reckitt Benckiser’s Mead Johnson Buyout Lead To A Home Care Spinoff?
Reckitt Benckiser (RBGLY) surprised the markets last week with its $16.6b (or $90 per share) bid for Enfamil maker and 2009 Bristol-Myers Squibb split off Mead Johnson Nutrition (MJN). Reckitt is known for owning a hodgepodge of ‘Powerbrands’ such as Lysol, Finish, Durex and Clearasil in the Health, Hygiene and Home sectors so it wasn’t really considered much of a… Read More »